Please enable JavaScript to continue using this application.

Compare $EXOZ vs $SER | Chartloom

Compare

$EXOZ vs $SER

eXoZymes Inc · Serina Therapeutics Inc

EXOZ

eXoZymes Inc

SER

Serina Therapeutics Inc

Compare $EXOZ vs $SER

Comparing eXoZymes Inc and Serina Therapeutics Inc

EXOZeXoZymes Inc

SERSerina Therapeutics Inc

EXOZeXoZymes Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-52.2%

52W performance

-66.1%

FCF yield

-14.7%

SERSerina Therapeutics Inc

Market cap

$30M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-64.5%

FCF yield

-70.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EXOZ

SER

Detailed metrics comparison

EXOZ

eXoZymes Inc

SER

Serina Therapeutics Inc

Market Cap

EXOZ$49M

SER$30M

Enterprise Value

EXOZ$43M

SER$10M

Price

EXOZ$5.25

SER$2.00

P/E Ratio

EXOZN/A

SERN/A

P/S Ratio

EXOZ0.00x

SER345.73x

EV/Sales

EXOZ0.00x

SER207.28x

EV/EBITDA

EXOZ0.00x

SER0.00x

P/B Ratio

EXOZ14.66x

SER2.66x

P/FCF Ratio

EXOZN/A

SERN/A

EV/FCF

EXOZ-6.04x

SER-0.47x

PEG Ratio

EXOZN/A

SERN/A

Forward P/E (NTM)

EXOZN/A

SERN/A

Forward P/S (NTM)

EXOZN/A

SERN/A

Revenue (TTM)

EXOZ$0

SER$0

Revenue Growth (YoY)

EXOZN/A

SERN/A

Forward Rev Growth

EXOZ0.0%

SER0.0%

Gross Margin (TTM)

EXOZ0.0%

SER65.1%

Operating Margin (TTM)

EXOZ0.0%

SER0.0%

EBITDA Margin (TTM)

EXOZ0.0%

SER0.0%

Net Margin (TTM)

EXOZ0.0%

SER0.0%

FCF Margin (TTM)

EXOZN/A

SERN/A

Net Income (TTM)

EXOZ$-10M

SER$-17M

FCF (TTM)

EXOZ$-7M

SER$-21M

EPS (TTM)

EXOZ-$1.18

SER-$1.03

ROE (TTM)

EXOZ-29213.0%

SER-10679.0%

ROA (TTM)

EXOZ-15866.0%

SER-9480.0%

ROIC (TTM)

EXOZ-28374.0%

SER-8268.0%

Cash

EXOZ$6M

SER$23M

Debt

EXOZ$87K

SER$3M

Net Cash/Debt

EXOZ$6M

SER$20M

Current Ratio (TTM)

EXOZ3.81x

SER6.65x

Quick Ratio (TTM)

EXOZ3.63x

SER6.12x

Debt/Equity (TTM)

EXOZ0.02x

SER0.16x

Debt/Assets (TTM)

EXOZ0.0%

SER0.0%

Interest Coverage (TTM)

EXOZN/A

SERN/A

Net Debt/EBITDA (TTM)

EXOZ0.00x

SER0.00x

Beta

EXOZ1.20

SER8.13

52W Performance

EXOZ-66.1%

SER-64.5%

YTD Performance

EXOZ-52.2%

SER-3.8%

% from 52W High

EXOZ-71.5%

SER-65.0%

% from 52W Low

EXOZ20.7%

SER63.9%

Asset Turnover (TTM)

EXOZ0.00x

SER0.02x

FCF Yield (TTM)

EXOZ-14.7%

SER-70.7%

Earnings Yield (TTM)

EXOZ-20.9%

SER-56.2%

Dividend Yield (TTM)

EXOZN/A

SERN/A

Rule of 40

EXOZ0.0

SER0.0

EV/GP/RG

EXOZN/A

SERN/A

Ticker research

View EXOZ research View SER research

Metric	EXOZ eXoZymes Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$49M	$30M
Enterprise Value	$43M	$10M
Price	$5.25	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	345.73x
EV/Sales	0.00x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.66x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.04x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-17M
FCF (TTM)	$-7M	$-21M
EPS (TTM)	-$1.18	-$1.03
ROE (TTM)	-29213.0%	-10679.0%
ROA (TTM)	-15866.0%	-9480.0%
ROIC (TTM)	-28374.0%	-8268.0%
Financial Health
Cash	$6M	$23M
Debt	$87K	$3M
Net Cash/Debt	$6M	$20M
Current Ratio (TTM)	3.81x	6.65x
Quick Ratio (TTM)	3.63x	6.12x
Debt/Equity (TTM)	0.02x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	8.13
52W Performance	-66.1%	-64.5%
YTD Performance	-52.2%	-3.8%
% from 52W High	-71.5%	-65.0%
% from 52W Low	20.7%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-14.7%	-70.7%
Earnings Yield (TTM)	-20.9%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EXOZ research	View SER research

Valuation

P/S Ratio

EXOZ

0.00x

SER

345.73x

EV/FCF

EXOZ

-6.04x

SER

-0.47x

Growth & revenue

Forward Revenue Growth

EXOZ

0.0%

SER

0.0%

Profitability & performance

Gross Margin

SER

65.1%

EXOZ

0.0%

ROE

SER

-10679.0%

EXOZ

-29213.0%

FCF Yield %

EXOZ

-14.7%

SER

-70.7%

52-Week Performance

SER

-64.5%

EXOZ

-66.1%

Detailed metrics comparison

EXOZ

eXoZymes Inc

SER

Serina Therapeutics Inc

Market Cap

EXOZ$49M

SER$30M

Enterprise Value

EXOZ$43M

SER$10M

Price

EXOZ$5.25

SER$2.00

P/E Ratio

EXOZN/A

SERN/A

P/S Ratio

EXOZ0.00x

SER345.73x

EV/Sales

EXOZ0.00x

SER207.28x

EV/EBITDA

EXOZ0.00x

SER0.00x

P/B Ratio

EXOZ14.66x

SER2.66x

P/FCF Ratio

EXOZN/A

SERN/A

EV/FCF

EXOZ-6.04x

SER-0.47x

PEG Ratio

EXOZN/A

SERN/A

Forward P/E (NTM)

EXOZN/A

SERN/A

Forward P/S (NTM)

EXOZN/A

SERN/A

Revenue (TTM)

EXOZ$0

SER$0

Revenue Growth (YoY)

EXOZN/A

SERN/A

Forward Rev Growth

EXOZ0.0%

SER0.0%

Gross Margin (TTM)

EXOZ0.0%

SER65.1%

Operating Margin (TTM)

EXOZ0.0%

SER0.0%

EBITDA Margin (TTM)

EXOZ0.0%

SER0.0%

Net Margin (TTM)

EXOZ0.0%

SER0.0%

FCF Margin (TTM)

EXOZN/A

SERN/A

Net Income (TTM)

EXOZ$-10M

SER$-17M

FCF (TTM)

EXOZ$-7M

SER$-21M

EPS (TTM)

EXOZ-$1.18

SER-$1.03

ROE (TTM)

EXOZ-29213.0%

SER-10679.0%

ROA (TTM)

EXOZ-15866.0%

SER-9480.0%

ROIC (TTM)

EXOZ-28374.0%

SER-8268.0%

Cash

EXOZ$6M

SER$23M

Debt

EXOZ$87K

SER$3M

Net Cash/Debt

EXOZ$6M

SER$20M

Current Ratio (TTM)

EXOZ3.81x

SER6.65x

Quick Ratio (TTM)

EXOZ3.63x

SER6.12x

Debt/Equity (TTM)

EXOZ0.02x

SER0.16x

Debt/Assets (TTM)

EXOZ0.0%

SER0.0%

Interest Coverage (TTM)

EXOZN/A

SERN/A

Net Debt/EBITDA (TTM)

EXOZ0.00x

SER0.00x

Beta

EXOZ1.20

SER8.13

52W Performance

EXOZ-66.1%

SER-64.5%

YTD Performance

EXOZ-52.2%

SER-3.8%

% from 52W High

EXOZ-71.5%

SER-65.0%

% from 52W Low

EXOZ20.7%

SER63.9%

Asset Turnover (TTM)

EXOZ0.00x

SER0.02x

FCF Yield (TTM)

EXOZ-14.7%

SER-70.7%

Earnings Yield (TTM)

EXOZ-20.9%

SER-56.2%

Dividend Yield (TTM)

EXOZN/A

SERN/A

Rule of 40

EXOZ0.0

SER0.0

EV/GP/RG

EXOZN/A

SERN/A

Ticker research

View EXOZ research View SER research

Metric	EXOZ eXoZymes Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$49M	$30M
Enterprise Value	$43M	$10M
Price	$5.25	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	345.73x
EV/Sales	0.00x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.66x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.04x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-17M
FCF (TTM)	$-7M	$-21M
EPS (TTM)	-$1.18	-$1.03
ROE (TTM)	-29213.0%	-10679.0%
ROA (TTM)	-15866.0%	-9480.0%
ROIC (TTM)	-28374.0%	-8268.0%
Financial Health
Cash	$6M	$23M
Debt	$87K	$3M
Net Cash/Debt	$6M	$20M
Current Ratio (TTM)	3.81x	6.65x
Quick Ratio (TTM)	3.63x	6.12x
Debt/Equity (TTM)	0.02x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	8.13
52W Performance	-66.1%	-64.5%
YTD Performance	-52.2%	-3.8%
% from 52W High	-71.5%	-65.0%
% from 52W Low	20.7%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-14.7%	-70.7%
Earnings Yield (TTM)	-20.9%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EXOZ research	View SER research